Snapshot from May 30, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Sun Pharma / Abbott Laboratories
competitor Processed

Sun Pharma & Abbott Laboratories

4 shared events · Importance 3 · Last updated Mar 31, 2026

Importance
3
Shared Events
4
Actions
0
Sentiment
26.666666666666668
Live sentiment trends, interaction importance charts, and action volume tracking available on the NewsDesk Dashboard
Relationship Summary

Sun Pharmaceutical Industries acts as a major competitor to Abbott Laboratories across various therapeutic segments and international markets.

Shared Events (4)
20
Business
Novo Nordisk Cuts Wegovy Price in India
Sun Pharma: Sun Pharma is among the Indian generic drugmakers expected to introduce lower-priced versions of semaglutide after Semaglutide's patent expires.
Abbott Laboratories: Abbott Laboratories is one of several Indian generic drugmakers poised to enter the market with lower-priced versions of semaglutide once Semaglutide loses patent exclusivity.
Nov 11, 2025 · 6 articles
0
Business
Novo Nordisk Cuts Ozempic, Wegovy Prices in India
Mar 30, 2026 · 8 articles
0
Business
Novo Nordisk Semaglutide Patent Expiry in India
Mar 20, 2026 · 8 articles
0
Business
Zydus, Lupin Co-Market Semaglutide in India
Mar 17, 2026 · 7 articles
NEWSDESK
Explore this relationship live

Track how Sun Pharma and Abbott Laboratories interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.